{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:45Z","timestamp":1791928965711,"version":"4.3.4"},"reference-count":40,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"10","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,8,19]]},"DOI":"10.1167\/iovs.67.10.45","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:30:40Z","timestamp":1787146240000},"page":"45","source":"Crossref","is-referenced-by-count":0,"title":["Effect of ARHGAP9 on Chemoresistance in High-Risk Advanced Retinoblastoma via the Rac1\/\u03b2-Catenin\/LEF1 Signaling Axis"],"prefix":"10.1167","volume":"67","author":[{"given":"Wenping","family":"Song","sequence":"first","affiliation":[{"name":"Department of Pharmacy, HNHC Key Laboratory of Anti-tumor Drug Research (Henan Cancer Hospital), Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China"},{"name":"Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Department of Oncology, Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Henan Provincial Chest Hospital, Chest Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Henan Provincial Chest Hospital, Chest Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Department of Oncology, Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Children's Hospital affiliated with Capital Medical University, National Center for Children's Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Yao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Department of Oncology, Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Children's Hospital affiliated with Capital Medical University, National Center for Children's Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Department of Oncology, Institute of Medicinal Biotechnology (IMB), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, HNHC Key Laboratory of Anti-tumor Drug Research (Henan Cancer Hospital), Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"9824","key":"bib1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"bib2","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.apjo.2024.100061","article-title":"Update on chemotherapy modalities for retinoblastoma: progress and challenges","volume":"13","author":"Kritfuangfoo","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"6","key":"bib3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4103\/IJO.IJO_2414_23","article-title":"Retinoblastoma\u2014a comprehensive review, update and recent advances","volume":"72","author":"Nag","year":"2024","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000524919","article-title":"Emerging new therapeutics for retinoblastoma","volume":"8","author":"Raval","year":"2022","journal-title":"Ocul Oncol Pathol"},{"issue":"1","key":"bib5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41420-021-00622-w","article-title":"Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA\/Myc\/Bcl2 axis","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov"},{"issue":"1","key":"bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1574892816666210806155754","article-title":"Rho GTPase activating protein 9 (ARHGAP9) in human cancers","volume":"17","author":"Song","year":"2022","journal-title":"Recent Patents Anticancer Drug Discov"},{"issue":"8","key":"bib7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrm.2016.67","article-title":"Regulating Rho GTPases and their regulators","volume":"17","author":"Hodge","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"bib8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","article-title":"Rho GTPases: regulation and roles in cancer cell biology","volume":"7","author":"Haga","year":"2016","journal-title":"Small GTPases"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","article-title":"Rho GTPase signaling in cancer progression and dissemination","volume":"102","author":"Crosas-Molist","year":"2022","journal-title":"Physiol Rev"},{"issue":"18","key":"bib10","doi-asserted-by":"publisher","first-page":"13864","DOI":"10.1074\/jbc.M700505200","article-title":"Non-canonical interaction of phosphoinositides with pleckstrin homology domains of Tiam1 and ArhGAP9","volume":"282","author":"Ceccarelli","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"bib11","doi-asserted-by":"publisher","first-page":"e36526","DOI":"10.1371\/journal.pone.0036526","article-title":"Structural analyses of the Slm1-PH domain demonstrate ligand binding in the non-canonical site","volume":"7","author":"Anand","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"bib12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0962-8924(02)00004-1","article-title":"Rho GTPase-activating proteins in cell regulation","volume":"13","author":"Moon","year":"2003","journal-title":"Trends Cell Biol"},{"issue":"5","key":"bib13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/cells8050382","article-title":"RAC1 takes the lead in solid tumors","volume":"8","author":"De","year":"2019","journal-title":"Cells"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"674426","DOI":"10.3389\/fonc.2021.674426","article-title":"Rac1, a potential target for tumor therapy","volume":"11","author":"Liang","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"bib15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/onc.2016.221","article-title":"KRT19 directly interacts with \u00df-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties","volume":"36","author":"Saha","year":"2017","journal-title":"Oncogene"},{"issue":"6592","key":"bib16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","article-title":"Functional interaction of beta-catenin with the transcription factor LEF-1","volume":"382","author":"Behrens","year":"1996","journal-title":"Nature"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"108098","DOI":"10.1016\/j.phrs.2026.108098","article-title":"Study on epigenetic regulatory mechanism of MBD4 with a germline loss-of-function mutation (rs140693) responsible for retinoblastoma chemoresistance via the cell cycle and apoptotic pathways","volume":"224","author":"Zhang","year":"2026","journal-title":"Pharmacol Res"},{"issue":"1","key":"bib18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12886-020-01348-6","article-title":"Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism","volume":"20","author":"Song","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"bib19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif)"},{"issue":"6","key":"bib20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","article-title":"Wnt signaling pathway: a comprehensive review","volume":"46","author":"Hayat","year":"2022","journal-title":"Cell Biol Int"},{"issue":"19","key":"bib21","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.3390\/cancers14194966","article-title":"Early mechanisms of chemoresistance in retinoblastoma","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"bib22","first-page":"476","article-title":"A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer","volume":"19","author":"Piao","year":"2020","journal-title":"Oncol Lett"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.2147\/CMAR.S201177","article-title":"The relevance between the immune response-related gene module and clinical traits in head and neck squamous cell carcinoma","volume":"11","author":"Song","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"9","key":"bib24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s41419-018-0976-0","article-title":"ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2\/E-cadherin","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.tice.2022.101817","article-title":"ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K\/AKT\/mTOR signaling pathway","volume":"77","author":"Sun","year":"2022","journal-title":"Tissue Cell"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12967-021-02733-5","article-title":"The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia","volume":"19","author":"Han","year":"2021","journal-title":"J Transl Med"},{"issue":"40","key":"bib27","doi-asserted-by":"publisher","first-page":"e39968","DOI":"10.1097\/MD.0000000000039968","article-title":"Upregulation of ARHGAP9 is correlated with poor prognosis and immune infiltration in clear cell renal cell carcinoma","volume":"103","author":"Xiong","year":"2024","journal-title":"Medicine"},{"issue":"1","key":"bib28","first-page":"965","article-title":"Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9","volume":"17","author":"Sun","year":"2019","journal-title":"Oncol Lett"},{"issue":"3","key":"bib29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1006\/bbrc.2001.5022","article-title":"Isolation of a novel human gene, ARHGAP9, encoding a rho-GTPase activating protein","volume":"284","author":"Furukawa","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"bib30","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.exer.2006.08.003","article-title":"Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma","volume":"83","author":"Adithi","year":"2006","journal-title":"Exp Eye Res"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"155199","DOI":"10.1016\/j.phymed.2023.155199","article-title":"Taxifolin inhibits melanoma proliferation\/migration impeding USP18\/Rac1\/JNK\/\u00df-catenin oncogenic signaling","volume":"123","author":"Xu","year":"2024","journal-title":"Phytomedicine"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"117976","DOI":"10.1016\/j.lfs.2020.117976","article-title":"Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1\/PAK1\/\u00df-catenin signaling axis","volume":"256","author":"Khan","year":"2020","journal-title":"Life Sci"},{"issue":"12","key":"bib33","doi-asserted-by":"publisher","first-page":"e1133","DOI":"10.1002\/ctm2.1133","article-title":"DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent \u00df-catenin nuclear accumulation","volume":"12","author":"Xiong","year":"2022","journal-title":"Clin Transl Med"},{"issue":"12","key":"bib34","first-page":"11979","article-title":"ARHGAP9 siRNA inhibits gastric cancer cell proliferation and EMT via inactivating Akt, p38 signaling and inhibiting MMP2 and MMP9","volume":"10","author":"Sun","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"bib35","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1002\/jcb.27127","article-title":"Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer","volume":"119","author":"Wang","year":"2018","journal-title":"J Cell Biochem"},{"key":"bib36","article-title":"Usage of ARHGAP9 gene as a predictive marker for prognosis and chemoresistance of retinoblastoma","author":"Li","year":"2023","journal-title":"China Patent ZL 2020107171139"},{"issue":"1","key":"bib37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u00df-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"bib38","doi-asserted-by":"publisher","first-page":"110684","DOI":"10.1016\/j.ygeno.2023.110684","article-title":"ARHGAP9 knockdown promotes lung adenocarcinoma metastasis by activating Wnt\/\u00df-catenin signaling pathway via suppressing DKK2","volume":"115","author":"Song","year":"2023","journal-title":"Genomics"},{"issue":"1","key":"bib39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12906-017-2023-6","article-title":"Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"bib40","first-page":"3","article-title":"Phenoxazine derivative, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one suppresses growth of human retinoblastoma cell line Y79 in vitro and in vivo","volume":"19","author":"Kimura","year":"2008","journal-title":"Oncol Rep"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.10.45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:20Z","timestamp":1791927140000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.10.45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.10.45","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}